TRIM28/TIF1B gene expression exhibits strong positive associations with sarcoma tumors (Shang et al, 2023) and serves as a prognostic predictor of immunotherapy resistance, regulating stemness, proliferation, and migration of cancer cells (Yang et al, 2023). Here, TRIM28 is linked to cancer.